© The Times of Israel
Israeli drug cuts COVID deaths by 70% in small study, company says
An Israeli drugmaker says a therapy it is developing reduced deaths among patients battling serious bouts of COVID-19 by 70 percent, and nearly halved hospitalization length in a small trial.